Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique

International Journal of Pharmaceutics

Volumn 355, Issue 1-2, 2008, Pages 277-284

  Li, Dong Xun ^a   Oh, Yu Kyuong ^b   Lim, Soo Jeong ^c   Kim, Jong Oh ^a   Yang, Ho Joon ^a   Sung, Jung Hoon ^a   Yong, Chul Soon ^a   Choi, Han Gon ^a  

^a Yeungnam University   (South Korea)

^b Korea University   (South Korea)

^c Sejong University   (South Korea)

Author keywords

Bioavailability; Ethanol; Gelatin; Ibuprofen; Microcapsule; Spray drying

Indexed keywords

GELATIN; IBUPROFEN;

AREA UNDER THE CURVE; ARTICLE; DISSOLUTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG SOLUBILITY; MAXIMUM PLASMA CONCENTRATION; MICROCAPSULE; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAY DRYING; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CAPSULES; CHEMISTRY, PHYSICAL; DESICCATION; ETHANOL; EXCIPIENTS; GELATIN; IBUPROFEN; MALE; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; SOLVENTS; X-RAY DIFFRACTION;

EID: 41549106217     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.12.020     Document Type: Article

References (27)

1. Ahn H.J., Kim K.M., and Kim C.K. Enhancement of bioavailability of ketoprofen using drug elixir as a novel dosage form. Drug Dev. Ind. Pharm. 24 (1998) 697-701
2. Canaparo R., Muntoni E., Zara G.P., Della, Pepa C., Berno E., Costa M., and Eandi M. Determination of Ibuprofen in human plasma by high-performance liquid chromatography: validation and application in pharmacokinetic study. Biomed. Chromatogr. 14 (2000) 219-226
3. Choi H.G., Oh Y.K., and Kim C.K. In-situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability. Int. J. Pharm. 165 (1998) 23-32
4. Choi H.G., Lee B.J., Yong C.S., Rhee J.D., Han J.H., Lee M.K., Park K.M., and Kim C.K. Terfenadine-β-cyclodextrin inclusion complex with the anti-histaminic activity enhancement. Drug Dev. Ind. Pharm. 27 (2001) 857-862
5. Geisslinger G., Dietzel K., Bezler H., Nuernberg B., and Brune K. Therapeutically relevant differences in the pharmacokinetical and pharmaceutical behavior of ibuprofen lysinate as compared to ibuprofen acid. Int. J. Clin. Pharmacol. Ther. Toxicol. 27 (1989) 324-328
6. Ghosh L.K., Ghosh N.C., Chatterjee M., and Gupta B.K. Product development studies on the tablet formulation of ibuprofen to improve bioavailability. Drug Dev. Ind. Pharm. 24 (1998) 473-477
7. Gillespie W.R., DiSanto A.R., Monovich R.E., and Albert K.S. Relative bioavailability of commercially available ibuprofen oral dosage forms in humans. J. Pharm. Sci. 71 (1982) 1034-1038
8. Glowka F.K. Stereoselective Pharmacokinetics of ibuprofen and its lysinate from suppositories in rabbits. Int. J. Pharm. 199 (2000) 159-166
9. Haikala V.E., Heimonen I.K., and Vuorela H.J. Determination of ibuprofen in ointments by reversed-phase liquid chromatography. J. Pharm. Sci. 80 (1991) 456-458
10. Kaka J.S., and Tekle A. Bioavailability of ibuprofen from oral and suppository preparations in rats. Res. Commun. Chem. Pathol. Pharmacol. 76 (1992) 171-182
11. Kim C.K., and Yoon Y.S. Developement of digoxin dry elixir as a novel dosage form using a spray-drying technique. J. Microencapsul. 12 (1995) 547-556
12. Kim C.K., Choi J.Y., Yoon Y.S., Gong J.P., Choi H.G., Kong J.Y., and Lee B.J. Preparation and evaluation of dry elixir for the enhancement of dissolution rate of poorly water-soluble drugs. Int. J. Pharm. 106 (1994) 25-32
13. Kim C.K., Yoon Y.S., and Kong J.Y. Preparation and evaluation of flurbiprofen dry elixir as a novel dosage form using a spray-drying technique. Int. J. Pharm. 120 (1995) 21-31
14. Kim C.K., Choi J.Y., Yoon Y.S., Gong J.P., Choi H.G., Kong J.Y., and Lee B.J. Preparation and evaluation of dry elixir for the enhancement of dissolution rate of poorly water-soluble drugs. Int. J. Pharm. 106 (1997) 25-32
15. Kokot Z., and Zmidzinska H. Solubility and dissolution rate of ibuprofen in ionic and non-ionic micellar systems. Acta Pol. Pharm. 58 (2001) 117-120
16. Lee S.W., Kim M.H., and Kim C.-K. Encapsulation of ethanol by spray drying technique: effects of sodium lauryl sulfate. Int. J. Pharm. 187 (1999) 193-198
17. Leising G., Resel R., Stelzer F., Tasch S., Lanziner A., and Hantich G. Physical aspect of dexibuprofen and racemic ibuprofen. J. Clin. Pharmacol. 36 (1996) 3-6
18. Menting L.C., and Hoogstad B. Volatile retention during the drying aqueous carbohydrate solutions. J. Food Sci. 32 (1967) 87-90
19. Menting L.C., Hoogstad B., and Thijssen H.A.C. Diffusion coefficient of water and organic volatiles in carbohydrate-water system. J. Food Technol. 5 (1970) 111-126
20. Sato, J., Kurusu, T., 1974. Process of manufacturing alcohol-containing solid matter. US Patent, 3,786,159.
21. Sato, J., Kurusu, T., Ota, M., 1982. Process for the preparation of alcohol-containing powders. UK Patent, GB2,110,235A.
22. Society of Toxicology (SOT), 1999. Guilding Priciples in the Use of Animals in Toxicology, www.toxicology.org/AI/FA/guidingprinciples.pdf.
23. Theis D.L., Lucisano L.J., and Halstead G.W. Use of stable isotopes for evaluation of drug delivery systems: comparison of ibuprofen release in vivo and in vitro from two biphasic release formulations utilizing different rate-controlling polymers. Pharm. Res. 11 (1994) 1069-1076
24. Thijssen H.A.C. Flavor retention in drying preconcentrated food liquids. J. Appl. Chem. Biotechnol. 21 (1971) 372-377
25. Venkateswarlu V., and Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J. Control. Rel. 95 (2004) 627-638
26. Walser S., Hruby R., Hesse E., Heinzl H., and Mascher H. Preliminary toxicokinetic study with different crystal forms of S (+)-ibuprofen (dexibuprofen) and R,S-ibuprofen in rats. Arzneimittelforschung. 47 (1997) 750-754
27. Yong C.S., Yang C.H., Rhee J.D., Lee B.J., Kim D.C., Kim D.D., Kim C.K., Choi J.S., and Choi H.G. Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and menthol. Int. J. Pharm. 269 (2004) 169-176